Le Lézard
Classified in: Health, Science and technology
Subject: EXE

February Is Low Vision Awareness Month: If You Have Vision Loss, Apply For A Free Currency Reader Today Or Download The EyeNote® 3.0 Mobile App!


WASHINGTON, Jan. 30, 2018 /PRNewswire-USNewswire/ -- In observance of Low Vision Awareness Month, the Bureau of Engraving and Printing (BEP), in partnership with the Library of Congress' National Library Service for the Blind and Physically Handicapped (NLS), reminds the public about the U.S. Currency Reader Program, which provides assistive technology at no cost to eligible applicants.  The currency reader, called iBill®, is a small hand-held device that denominates all U.S. currency in circulation to assist people who are blind or visually impaired. 

EyeNote® 3.0 Mobile App

To date, more than 59,000 currency readers have been distributed to eligible U.S. citizens and legal residents.  "Over the years we have received extremely positive responses from the blind and visually impaired community, cash handlers, and business owners about the usefulness of the currency readers and mobile apps," said BEP Director Len Olijar.  "If you are blind or visually impaired, I encourage you to apply for a currency reader or download one of our mobile apps today.  And if you know someone who is blind or visually impaired, please let them know about this program."

The iBill® operates in one of three modes:  a clear natural voice, a pattern of tones, or a pattern of vibrations for privacy.  The vibration mode also assists people who are deaf and blind in identifying a note's denomination.  The device uses a single AAA battery, which is included.

To request a currency reader, individuals should complete the application located on BEP's website at http://www.bep.gov/uscurrencyreaderform.html or call (844) 815-9388, toll free, to request that an application be mailed. 

BEP also offers two mobile device applications that denominate currency by allowing users to scan a note and have the note's value communicated, EyeNote® and the IDEAL® Currency Identifier.  EyeNote 3.0®, our latest release, is 64-bit and compatible with Apple iOS 11 mobile applications; it can be downloaded free from the Apple App Store.  The IDEAL® Currency Identifier app for Android devices can be downloaded free from Google Play.  To date, there have been more than 50,000 downloads of BEP-sponsored mobile applications.

For additional information about the U.S. Currency Reader Program or our mobile apps, please visit BEP's website at http://www.bep.gov/resources/meaningfulaccess.html.  For more updates, follow us on Twitter and Facebook at @USMoneyfactory.

Contact: Lydia Washington
[email protected]
(202) 874-3487

SOURCE Bureau of Engraving and Printing


These press releases may also interest you

at 17:55
City of Hope®, one of the largest cancer research and treatment organizations in the United States, has been awarded $5.4 million from the California Institute for Regenerative Medicine (CIRM) to build and fund a stem cell research laboratory on its...

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...



News published on and distributed by: